Zhao M, Xu Z, Wu L, Wei Z, et al. Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial. Br J Dermatol 2025 Nov 24:ljaf455. doi: 10.1093.
PMID: 41284735